Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,466 | 212 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $716.96 | 42 | $0 (2021) |
| Allergan, Inc. | $584.42 | 18 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $558.75 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $378.96 | 24 | $0 (2023) |
| Kala Pharmaceuticals, Inc. | $279.63 | 7 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $270.57 | 9 | $0 (2024) |
| TISSUETECH, INC. | $266.15 | 7 | $0 (2021) |
| Shire North American Group Inc | $230.60 | 9 | $0 (2019) |
| CooperVision Inc. | $222.05 | 10 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $169.95 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $631.06 | 39 | Bausch & Lomb Americas Inc. ($384.73) |
| 2023 | $514.31 | 33 | Bausch & Lomb Americas Inc. ($149.07) |
| 2022 | $540.39 | 21 | BioTissue Holdings, Inc. ($129.00) |
| 2021 | $1,148 | 52 | Allergan, Inc. ($268.08) |
| 2020 | $300.69 | 13 | TissueTech, Inc. ($130.54) |
| 2019 | $515.86 | 25 | Bausch & Lomb, a division of Bausch Health US, LLC ($212.16) |
| 2018 | $383.66 | 15 | Bausch & Lomb, a division of Bausch Health US, LLC ($292.05) |
| 2017 | $432.61 | 14 | Valeant Pharmaceuticals North America LLC ($138.30) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Bausch & Lomb Americas Inc. | BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $6.45 | General |
| 10/29/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Ophthalmology | ||||||
| 10/24/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: SOLUTION/ DROPS | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| 10/10/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Ophthalmology | ||||||
| 08/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/19/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | Bausch & Lomb Americas Inc. | BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $7.87 | General |
| 06/21/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Ophthalmology | ||||||
| 06/13/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Devices | ||||||
| 06/07/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Ophthalmology | ||||||
| 05/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Ophthalmology | ||||||
| 05/20/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Dry eyes | ||||||
| 05/12/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $13.64 | General |
| 04/30/2024 | Bausch & Lomb Americas Inc. | BIOTRUE ONE DAY (Device), INFUSE | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 340 | 514 | $69,630 | $36,284 |
| 2022 | 7 | 260 | 407 | $55,040 | $29,445 |
| 2021 | 7 | 189 | 271 | $33,170 | $18,514 |
| 2020 | 6 | 146 | 159 | $17,115 | $8,648 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 24 | 163 | $30,270 | $16,265 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 75 | $11,250 | $6,606 | 58.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 106 | $10,600 | $6,109 | 57.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $6,290 | $3,592 | 57.1% |
| 92250 | Photography of the retina | Office | 2023 | 88 | 90 | $7,200 | $2,291 | 31.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 18 | 19 | $1,995 | $798.66 | 40.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 16 | 16 | $1,200 | $381.60 | 31.8% |
| 92134 | Imaging of retina | Office | 2023 | 11 | 11 | $825.00 | $241.60 | 29.3% |
| 68761 | Closure of tear duct opening using plug | Office | 2022 | 20 | 129 | $23,495 | $13,225 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 81 | $8,060 | $5,119 | 63.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $7,030 | $4,328 | 61.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 47 | $7,035 | $3,948 | 56.1% |
| 92250 | Photography of the retina | Office | 2022 | 65 | 66 | $5,280 | $1,625 | 30.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 20 | 23 | $2,415 | $726.64 | 30.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 18 | 23 | $1,725 | $472.59 | 27.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2021 | 16 | 62 | $11,470 | $6,644 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 70 | $5,600 | $4,240 | 75.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 31 | $4,185 | $2,724 | 65.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $5,220 | $2,711 | 51.9% |
| 92250 | Photography of the retina | Office | 2021 | 37 | 40 | $3,200 | $987.26 | 30.9% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 16 | 19 | $1,995 | $754.22 | 37.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 16 | 20 | $1,500 | $452.37 | 30.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $3,960 | $2,309 | 58.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 30 | $4,095 | $2,222 | 54.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 40 | $3,200 | $1,937 | 60.5% |
About Dr. Maia Moyer-Hazen, OD
Dr. Maia Moyer-Hazen, OD is a Optometrist healthcare provider based in Strasburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1972944742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maia Moyer-Hazen, OD has received a total of $4,466 in payments from pharmaceutical and medical device companies, with $631.06 received in 2024. These payments were reported across 212 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,466).
As a Medicare-enrolled provider, Moyer-Hazen has provided services to 935 Medicare beneficiaries, totaling 1,351 services with total Medicare billing of $92,892. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Strasburg, PA
- Active Since 07/09/2013
- Last Updated 02/20/2018
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1972944742
Products in Payments
- XIIDRA (Drug) $682.91
- BTOD (Device) $304.55
- INFUSE (Device) $291.07
- Cequa (Drug) $270.57
- BIOTRUE ONE DAY (Device) $255.01
- ULTRA (Device) $231.69
- Prokera (Device) $216.19
- VUITY (Drug) $214.29
- RESTASIS MULTIDOSE (Drug) $205.55
- PROKERA (Device) $192.98
- INVELTYS (Drug) $154.64
- EYSUVIS (Drug) $148.46
- TYRVAYA (Drug) $133.36
- VYZULTA (Drug) $111.58
- MyDay Contact Lens (Device) $104.58
- RESTASIS (Drug) $100.52
- Clariti Contact Lens (Device) $100.04
- COMBIGAN (Drug) $98.75
- LUMIGAN (Drug) $74.67
- XDEMVY (Drug) $70.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.